Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- Last sale before this period: Mar 12, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dexcom (DXCM) | President, CEO, and Director, Director | Mar 15, 2017 | Aug 25, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 22, 2026, Dexcom: 1,451 shares withheld by the company for taxes. 1 filing: 1
- May 22, 2026, Dexcom: 1,451 shares withheld by the company for taxes. 1 filing: 1
- Mar 8, 2026, Dexcom: 104,516 shares granted; 19,757 shares withheld by the company for taxes. 1 filing: 1
- Jan 29, 2026, Dexcom: 8,310 shares awarded; 3,058 shares withheld by the company for taxes. 1 filing: 1
- Nov 10, 2025, Dexcom: bought 18,200 shares for $1.0M. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.